These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6826327

  • 21. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.
    Hazlett LD, Berk RS.
    Infect Immun; 1984 Mar; 43(3):783-90. PubMed ID: 6698607
    [Abstract] [Full Text] [Related]

  • 22. Role of innate and adaptive immunity in the pathogenesis of keratitis.
    Hazlett LD.
    Ocul Immunol Inflamm; 2005 Mar; 13(2-3):133-8. PubMed ID: 16019672
    [Abstract] [Full Text] [Related]

  • 23. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N, Willcox MD, Fleiszig SM, Stapleton F, Bao B, Tout S, Husband A.
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [Abstract] [Full Text] [Related]

  • 24. Pseudomonas eye infections in cyclophosphamide-treated mice.
    Hazlett LD, Rosen DD, Berk RS.
    Invest Ophthalmol Vis Sci; 1977 Jul; 16(7):649-52. PubMed ID: 873724
    [Abstract] [Full Text] [Related]

  • 25. The role of nitric oxide in resistance to P. aeruginosa ocular infection.
    Hazlett LD, McClellan S, Goshgarian C, Huang X, Thakur A, Barrett R.
    Ocul Immunol Inflamm; 2005 Jul; 13(4):279-88. PubMed ID: 16159718
    [Abstract] [Full Text] [Related]

  • 26. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa.
    Kernacki KA, Berk RS.
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):16-23. PubMed ID: 7822143
    [Abstract] [Full Text] [Related]

  • 27. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA, Zhang Y, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [Abstract] [Full Text] [Related]

  • 28. Role of nitric oxide in P. aeruginosa keratitis caused by distinct bacterial phenotypes.
    Wang W, Xue M, Willcox M, Thakur A.
    Eye Contact Lens; 2008 Jul; 34(4):195-7. PubMed ID: 18787424
    [Abstract] [Full Text] [Related]

  • 29. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice.
    Hazlett LD, Zucker M, Berk RS.
    Ophthalmic Res; 1992 Jul; 24(1):32-9. PubMed ID: 1608590
    [Abstract] [Full Text] [Related]

  • 30. Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.
    Zaidi TS, Zaidi T, Pier GB.
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2085-93. PubMed ID: 19892865
    [Abstract] [Full Text] [Related]

  • 31. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections.
    Ramphal R, McNiece MT, Polack FM.
    Ann Ophthalmol; 1981 Apr; 13(4):421-5. PubMed ID: 6787968
    [Abstract] [Full Text] [Related]

  • 32. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis.
    Engelbert M, Gilmore MS.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2479-86. PubMed ID: 15980239
    [Abstract] [Full Text] [Related]

  • 33. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [Abstract] [Full Text] [Related]

  • 34. Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: investigation of the role of host complement in poxvirus pathogenesis.
    Miller CG, Justus DE, Jayaraman S, Kotwal GJ.
    Cell Immunol; 1995 May; 162(2):326-32. PubMed ID: 7743560
    [Abstract] [Full Text] [Related]

  • 35. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.
    Cerquetti MC, Sordelli DO, Bellanti JA, Hooke AM.
    Infect Immun; 1986 Jun; 52(3):853-7. PubMed ID: 3086235
    [Abstract] [Full Text] [Related]

  • 36. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [Abstract] [Full Text] [Related]

  • 37. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Miller TE, Phillips S, Simpson IJ.
    Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
    [Abstract] [Full Text] [Related]

  • 38. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS, Zhou X, Schulte DP, Wilson PM, Fish B, Moulder J.
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [Abstract] [Full Text] [Related]

  • 39. The role of C3 as an opsonin in the early stages of infection.
    Winkelstein JA, Smith MR, Shin HS.
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):397-401. PubMed ID: 1153415
    [Abstract] [Full Text] [Related]

  • 40. Pseudomonas aeruginosa keratitis in IL-6-deficient mice.
    Cole N, Bao S, Stapleton F, Thakur A, Husband AJ, Beagley KW, Willcox MD.
    Int Arch Allergy Immunol; 2003 Feb; 130(2):165-72. PubMed ID: 12673071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.